Non-peptide Opioid Receptor Ligands - Recent Advances. Part II - Antagonists

Title: Non-peptide Opioid Receptor Ligands - Recent Advances. Part II - Antagonists

Volume: 9 Issue: 17

Author(s): Agnieszka Kaczor and Dariusz Matosiuk

Affiliation:

Keywords: non-peptide opioid receptor, norbinaltorphimine derived ligands, de novo methodology, pharmacophore models, pyrrolomorphinans, kappa opioid receptor

Abstract: This paper is the second part of the review on opioid receptor ligands and deals with the progress in the field of non-peptide opioid receptor antagonists (starting from the pioneering opiate studies in the early seventies) with particular stress on the last decade accomplishments. As X-ray high resolution structure determination of the ligand-receptor systems for G protein-coupled receptors meets with considerable experimental obstacles, the knowledge about ligand interactions with the membrane-bound receptors traditionally derives from structure-activity studies. Hence, such a concise summary, collecting chemically distinct but pharmalogically relative compounds, may be a convenient information source for any research concerning ligand-opioid receptor binding or rational drug design.

Cite this article as:

Kaczor Agnieszka and Matosiuk Dariusz, Non-peptide Opioid Receptor Ligands - Recent Advances. Part II - Antagonists, Current Medicinal Chemistry 2002; 9 (17) . https://dx.doi.org/10.2174/0929867023369358